BioSpace News Archive

HotSpot Therapeutics, Inc announced today that the company management will present and host one-on-one meetings at the virtual Solebury Trout/BMO Fall Private Company Showcase 2021.

Titan to Evaluate and Potentially Licence Tetrapeptide Kappa-Opioid Agonist Compounds for use in Combination with its ProNeura® Technology Platform -

Aethlon Medical, Inc., a company developing medical technology to treat cancer and life-threatening infectious disease, announced the publication of a manuscript in the peer-reviewed journal Frontiers in Medicine describing two cases of critically ill COVID-19 patients treated with the Hemopurifier®, Aethlon’s therapeutic blood filtration system.

Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced the appointment of Harry Thomasian Jr. as the Company’s chief financial officer (CFO), effective October 18, 2021.

RayzeBio, Inc. appointed Mary Tagliaferri, M.D. to its board of directors effective September 29, 2021.

Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company developing STAR-0215 for the treatment of hereditary angioedema (HAE), today announced it will be presenting “Burdens of Disease and Treatment in Hereditary Angioedema: Interview Insights from HAE Patients” at the 2021 NORD Rare Diseases and Orphan Products Breakthrough Summit.

Syros Pharmaceuticals (NASDAQ:SYRS), a leader in the development of medicines that control the expression of genes, today announced the appointment of Jason Haas as Chief Financial Officer.

CG Oncology, Inc. announced today acceptance of an oral presentation and a poster presentation at The Society for Immunotherapy of Cancer (SITC) Annual Meeting, held virtually and in-person in Washington, DC, November 10-14, 2021.

Sesen Bio today announced the expansion of its chemistry, manufacturing, and control (CMC) and clinical development teams with the hiring of Eun Jang as Senior Director, Analytical Sciences, and Chèrie Kaefring as Director, Clinical Operations.

IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) will announce its third-quarter 2021 financial results before the market opens on Thursday, October 21, 2021.